Poly Medicure Limited (POLYMED.BO) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-26). See the full ratio breakdown and business-activity screen below for the reasoning.
Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2026-03-31. POLYMED.BO files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.14% | 30.00% | Pass |
| Interest-bearing investments | 5.12% | 30.00% | Pass |
| Non-permissible income | 0.69% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 9.33% | 33.00% | Pass |
| Interest-bearing investments | 22.27% | 33.00% | Pass |
| Non-liquid assets | 64.18% | at least 20.00% | Pass |
| Non-permissible income | 0.69% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 9.33% | 33.33% | Pass |
| Cash + interest-bearing securities | 22.27% | 33.33% | Pass |
| Accounts receivable | 35.82% | 33.33% | Fail |
| Non-permissible income | 0.69% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 9.33% | 33.33% | Pass |
| Cash + interest-bearing securities | 22.27% | 33.33% | Pass |
| Accounts receivable | 35.82% | 50.00% | Pass |
| Non-permissible income | 0.69% | 5.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.89% | 33.00% | Pass |
| Cash + interest-bearing securities | 4.51% | 33.00% | Pass |
| Accounts receivable | 2.74% | 33.00% | Pass |
| Non-permissible income | 0.69% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.04% | 33.00% | Pass |
| Cash + interest-bearing securities | 4.86% | 49.00% | Pass |
| Accounts receivable | 2.96% | 49.00% | Pass |
| Non-permissible income | 0.69% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.04% | 33.33% | Pass |
| Cash + interest-bearing securities | 4.86% | 33.33% | Pass |
| Accounts receivable | 7.83% | 49.00% | Pass |
| Non-permissible income | 0.69% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 50.60 | NEUTRAL |
| Stochastic %K (14) | 33.17 | NEUTRAL |
| CCI (20) | -37.51 | NEUTRAL |
| Williams %R (14) | -66.83 | NEUTRAL |
| MACD (12,26,9) | -4.44 | SELL |
| ROC (10) | 1.69 | BUY |
| Momentum (10) | 28.90 | BUY |
| EMA (10) | 1739.51 | SELL |
| SMA (10) | 1744.41 | SELL |
| EMA (20) | 1738.73 | SELL |
| SMA (20) | 1742.89 | SELL |
| EMA (30) | 1730.38 | BUY |
| SMA (30) | 1746.62 | SELL |
| EMA (50) | 1703.31 | BUY |
| SMA (50) | 1715.58 | BUY |
| EMA (100) | 1653.32 | BUY |
| SMA (100) | 1619.17 | BUY |
| EMA (200) | 1668.87 | BUY |
| SMA (200) | 1583.27 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Medical Instruments & Supplies
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, including I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA balloon dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, including blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, and foley balloon and urine drainage catheters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.
Background via Yahoo Finance — informational, not part of the verdict.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-08 · Asset managers net 912361 (-21819)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.